Multiple antihypertensive peptides derived from bovine casein and whey proteins inhibit ACE and lower blood pressure, with some (IPP, VPP) showing clinical benefit — functional food peptides for cardiovascular health.
Key findingCasein-derived (IPP, VPP, alpha-casein fragments) and whey-derived (alpha-lactalbumin, beta-lactoglobulin peptides) ACE-inhibitory peptides lower bloo
What the researchers found
Casein-derived (IPP, VPP, alpha-casein fragments) and whey-derived (alpha-lactalbumin, beta-lactoglobulin peptides) ACE-inhibitory peptides lower blood pressure in animal and human studies — the most validated functional food peptides for cardiovascular health.
Why it matters
Relevant for bioactive-food-peptides, cardiovascular.
How the study worked
review study.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2008.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Antihypertensive peptides derived from bovine casein and whey proteins.
Advances in experimental medicine and biology, 606, 295-317
Citation
Saito, Tadao. (2008). Antihypertensive peptides derived from bovine casein and whey proteins.. Advances in experimental medicine and biology, 606, 295-317. https://doi.org/10.1007/978-0-387-74087-4_12